Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Project Scope

This project team will create a users guide or White Paper with recommendations for analysis and displays for Laboratory Data, with a focus on Phase 2-4 clinical trials and integrated submission documents. There have been 2 previous White Papers on this topic (1 for central tendency in 2013 and 1 for Outliers/Shifts in 2015). This paper will combine two method types and update recommendations given the advancement in interactive options. 



Project LeadsEmail
Charles Beasley (, Beasley Pharmaceutical and Biotechnology Consulting)charlesmbeasleyjr@msn.com
Christopher Smith (, FDA)christopher.smith2@fda.hhs.gov

Objectives & Deliverables 

Timelines 

Align on next steps 

Nicola Newton, PHUSE Project Assistant

nicky@phuse.global

Q2 2023


Status
colourBlue
titleCurrent Status
Q1 Q3 2023

Project currently on holdClosed.



Objectives & Deliverables 

Timelines 

Align on next steps 

Q2 2023
Project MembersOrganisationAmelia PangSanofiEdward RauschEli LillyHongli LuMerckJennifer McGrogan Reata PharmaceuticalsKirthi RangarajuPfizerMary NilssonEli LillyMaria DaltonGSKMario WidelReata PharmaceuticalsMercy NavarroGenentechMiri Kramer MediwoundNancy BruckenCSGNeeta LaddhaParexel Nhi BeasleyFDARahal Hamza IQVIARaj PhadtareCorvus PharmaceuticalsRebeka RevisIQVIARobert (Mac) GordonJanssen Research & DevelopmentSumit PradhanIndustryShayami ThanabalasundrumEli LillySong Liu Novo NordiskSoujanya KondaIQVIAVenkata DaltaGenmabWei Wang Eli Lilly Xuewei (Sherry) Cui Eli Lilly